Cell-based therapy for kidney disease

Cell-based therapy for kidney disease

The prevalence of renal disease continues to increase worldwide. When normal kidney is injured, the damaged renal tissue undergoes pathological and physiological events that lead to acute and chronic kidney diseases, which frequently progress to end stage renal failure. Current treatment of these renal pathologies includes dialysis, which is incapable of restoring full renal function. To addres...

Cell Therapy in Cardiovascular Disease

  Recently, cell therapy has sparked a revolution in ischemic heart disease that will in the future help clinicians to cure patients. Earlier investigations in animal models and clinical trials have suggested that positive paracrine effects such as neoangiogenesis and anti-apoptotic can improve myocardial function. In this regard the Royan cell therapy center designed a few trials in collaborat...

Stem cell therapy for kidney disease--present and future.

P137: Stem Cell Therapy in Alzheimer’s Disease

Alzheimer disease (AD) is a progressive neurodegenerative brain disorder which plays an important role in neural cell destruction and as a result it causes memory loss in the patients. This disease is also the most common type of dementia which doesn’t completely respond to medical treatments so no certain cure is available. Recent studies show the advantages of using stem cells (SCs) in ...

Cell-Based Regenerative Therapy for Liver Disease

The liver can regenerate itself in response to acute liver damage. However, chronically induced liver dysfunction interferes with the liver regeneration process and increases the risk of onset of more severe hepatic failure, including hepatic cirrhosis and liver cancer. To develop more effi cient therapeutics for chronic liver diseases, cell-based regenerative therapies using functional hepatoc...